Mednet Logo
HomeRadiation OncologyQuestion

Would you offer hypofractionated PMRT to a pathologic T2N1a BRCA positive patient?

1
4 Answers
Mednet Member
Mednet Member
Radiation Oncology · Beth Israel Deaconess Medical Center

I would irradiate this patient due to the combination of a positive node and LVI, regardless of her age. I define "young" as age 40 years or younger; others use age 35 to 45 as cut-offs. It's not clear what this patient's age is based upon the information given.

All of the data to date from randomize...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Allegheny Health Network, Pittsburgh

I would consider PMRT for this patient given nodal involvement, LVI, and young age with single node involved without ALND.

I typically use standard fractionation postmastectomy if reconstruction is present until we have mature outcomes from RT-CHARM.

If non-reconstructed, I'd consider hypofractionat...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

BRCA has not been shown in any study to enhance RT effect or cause increased late morbidity with RT. I would offer PMRT with hypofractionation.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · New York Cancer and Blood Specialists

I prefer conventional fractionation for PMRT with regional LN.

Register or Sign In to see full answer

Would you offer hypofractionated PMRT to a pathologic T2N1a BRCA positive patient? | Mednet